Close [X]
Companies & Industry »Company News»Company News Details
Company News Details

BSE   24 Mar 17 | 12:00 AM

446.20 -0.7 (-0.16%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   24 Mar 17 | 12:00 AM

445.50 -2.45 (-0.55%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 443.75 (0.55%)
1 Month : Rs 430.05 (3.76%)
1 Year : Rs 320.30 (39.31%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine

Sensex

Company Price Gain (%)
ICICI Bank274.802.90
St Bk of India276.052.81
GAIL (India)381.251.17
ITC281.051.13
Reliance Inds.1,286.200.95

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine